Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,612.90
+3.20 (0.20%)
Sep 12, 2025, 11:30 AM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 3.86 trillion as of September 11, 2025. Its market cap has decreased by -9.35% in one year.
Market Cap
3.86T
Enterprise Value
3.63T
Revenue
537.77B
Ranking
n/a
PE Ratio
37.22
Stock Price
1,612.90
Market Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 3.86T, an increase of 13,888.09%. That is a compound annual growth rate of 22.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2025 | 3,823.10B | -15.53% |
Dec 31, 2024 | 4,525.99B | 49.78% |
Dec 29, 2023 | 3,021.84B | 25.77% |
Dec 30, 2022 | 2,402.69B | 18.41% |
Dec 31, 2021 | 2,029.07B | 42.77% |
Dec 31, 2020 | 1,421.25B | 36.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Divi's Laboratories | 1,593.48B |
Cipla | 1,253.31B |
Apollo Hospitals Enterprise | 1,125.19B |
Mankind Pharma | 1,076.68B |
Zydus Lifesciences | 1,042.06B |
Fortis Healthcare | 730.16B |
Alkem Laboratories | 638.00B |
Aurobindo Pharma | 610.02B |